How do customers and pharmacists experience generic substitution?

International Journal of Pharmaceutical and Healthcare Marketing

Volumn 4, Issue 4, 2010, Pages 375-395

  Gill, Liz ^a   Helkkula, Anu ^b   Cobelli, Nicola ^c   White, Lesley ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b AALTO UNIVERSITY   (Finland)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

Australia; Consumer behaviour; Finland; Generics; Italy; Medicines

Indexed keywords

EID: 78649285195     PISSN: 17506123     EISSN: None     Source Type: Journal    
DOI: 10.1108/17506121011095218     Document Type: Article

References (72)

1. Aalto-Setälä, V. (2008), "The impact of generic substitution on price competition in Finland" in The European Journal of Health Economics, Vol. 9, No. 2, pp. 185-91.
2. Al-Gedadi, N.A. and Hassali, M.A. (2008), "Pharmacists' views on generic medicines: a review of the literature" in Journal of Generic Medicines, Vol. 5, No. 3, pp. 209-18.
3. Allenet, B. and Barry, H. (2003), "Opinion and behaviour of pharmacists towards the substitution of branded drugs by generic drugs: survey of 1,000 French community pharmacists" in Pharmacy World and Science, Vol. 25, No. 5, pp. 197-202.
4. Andersson, E.M., Hallberg, I.R. and Edberg, A.K. (2003), "Nurses' experiences of the encounter with elderly patients in acute confusional state in orthopaedic care" in International Journal of Nursing Studies, Vol. 40, No. 4, pp. 437-48.
5. Banahan, B. and Kolassa, E.M. (1997), "A physician survey on generic drugs and substitution of critical dose medications" in Archives of Internal Medicine, Vol. 157, No. 18, pp. 2080-8.
6. Bearden, W.O. and Mason, J.B. (1980), "Determinants of physician and pharmacist support of generic drugs" in Journal of Consumer Research, Vol. 7, No. 2, pp. 121-30.
7. Beecroft, G. (2007), "Generic drug policy in Australia: a community pharmacy perspective" in Australian and New Zealand Health Policy, Vol. 4, No. 7, pp. 1-7.
8. Bissell, P., Ryan, K. and Morecroft, C. (2006), "Narratives about illness and medication: a neglected theme/new methodology within pharmacy practice research. Part I: conceptual framework" in Pharmacy World & Science, Vol. 28, No. 2, pp. 54-60.
9. Brodell, R.T., Helms, S.E., Rao, I.K. and Bredle, D.L. (1997), "Prescription errors: legibility and drug name confusion" in Archives of Family Medicine, Vol. 6, No. 3, pp. 296-8.
10. Bury, M. (2001), "Illness narratives: fact or fiction?" in Sociology of Health & Illness, Vol. 23, No. 3, pp. 263-85.
11. Carvalho, M.C., Accioly Jùnior, H. and Raffin, F.N. (2006), "Representações sociais do medicamento genérico por consumidores residentes em Natal, Rio Grande do Norte, Brasil" in Cadernos de Saúde Pública, Vol. 22, No. 3, pp. 653-61.
12. Chua, G.N., Hassali, M.A., Shafie, A.A. and Awaisu, A. (2010), "A survey exploring knowledge and perceptions of general practitioners towards the use of generci medicines in the northen state of Malysia" in Health Policy, Vol. 95, Nos 2/3, pp. 229-35.
13. Cohen, M. (1999), "Insights into consumer confusion" in Consumer Policy Review, Vol. 9, No. 6, pp. 210-13.
14. DeLorme, D.E., Huh, J. and Reid, L.N. (2007), "Seniors' perceptions of prescription drug information sources" in International Journal of Pharmaceutical and Health Care Marketing, Vol. 1, No. 2, pp. 107-27.
15. Deselle, S.P. (2001), "Determinants of satisfaction with prescription drug plans" in American Journal of Health-System Pharmacy, Vol. 58, No. 12, pp. 1110-19.
16. Ess, S., Schneeweiss, S. and Szucs, T. (2003), "European healthcare policies for controlling drug expenditure" in PharmacoEconomics, Vol. 21, No. 2, pp. 89-103.
17. Estelami, H. (2005), "A cross-category examination of consumer price awareness in financial and non-financial services" in Journal of Financial Services Marketing, Vol. 10, No. 2, pp. 125-39.
18. Gaither, C., Kirking, D.M., Ascione, F.J. and Welage, L.S. (2001), "Consumers' views on generic medications" in Journal of the American Pharmaceutical Association, Vol. 41, No. 5, pp. 729-36.
19. Ganther, J. and Kreling, D. (2000), "Consumer perceptions of risk and required cost savings for generic prescription drugs" in Journal of the American Pharmaceutical Association, Vol. 40, No. 3, pp. 378-83.
20. Garattini, L. and Tediosi, F. (2000), "A comparative analysis of generics markets in five European countries" in Health Policy, Vol. 51, No. 3, pp. 149-62.
21. Ghislandi, S., Krulichova, I. and Garattini, L. (2005), "Pharmaceutical policy in Italy: towards a structural change?" in Health Policy, Vol. 72, No. 1, pp. 53-63.
22. Glaser, B.G. (1978), Theoretical Sensitivity: Advances in the Methodology of Grounded Theory, The Scientology Press, Mill Valley, CA.
23. Goulding, C. (2005), "Grounded theory, ethnography and phenomenology: a comparative analysis of three qualitative strategies for marketing research" in European Journal of Marketing, Vol. 39, No. 3, pp. 294-308.
24. Gummesson, E. (1999), Total Relationship Marketing: Rethinking Marketing Management from 4Ps to 30Rs, Butterworth Heinemann, Oxford.
25. Haskins, L.S., Tomaszewski, K.J. and Crawford, P. (2005), "Patient and physician reactions to generic antiepileptic substitution in the treatment of epilepsy" in Epilepsy and Behavior, Vol. 7, No. 1, pp. 98-105.
26. Hassali, M.A., Kong, D.C.M. and Stewart, K. (2006), "Generic medicines: perceptions of general practitioners in Melbourne, Australia" in Journal of Generic Medicines, Vol. 3, No. 3, pp. 214-25.
27. Hassali, M.A., Shafie, A.A., Jamshed, S., Ibrahim, M.I.M. and Awaisu, A. (2009), "Consumers' views on generic medicines: a review of the literature" in International Journal of Pharmacy Practice, Vol. 17, No. 2, pp. 79-88.
28. Heikkilä, R., Mäntyselkä, P., Hartikainen-Herranen, K. and Ahonen, R. (2007), "Customers' and physicians' opinions of and experiences with generic substitution during the first year in Finland" in Health Policy, Vol. 82, No. 3, pp. 366-74.
29. Helkkula, A. (2010), "Service experience in an innovation context", Hanken School of Economics, Ekonomi och Samhälle, Helsinki, doctoral thesis.
30. Himmel, W., Simmenroth-Nayda, A., Niebling, W., Ledig, T., Jansen, R-D., Kochen, M.M., Gleiter, C.H. and Hummers-Pradier, E. (2005), "What do primary care patients think about generic drugs?" in International Journal of Clinical Pharmacology and Therapeutics, Vol. 43, No. 10, pp. 472-9.
31. Holbrook, M.A. and Hirschman, E.C. (1982), "The experiential aspects of consumption: consumer fantasy, feelings and fun" in Journal of Consumer Research, Vol. 9, No. 2, pp. 132-40.
32. Ioannides-Demos, L., Ibrahim, J. and McNeil, J. (2002), "Reference-based pricing schemes: effect on pharmaceutical expenditure, resource utilisation and health outcomes" in PharmacoEconomics, Vol. 20, No. 9, pp. 577-91.
33. Iosifescu, A., Halm, E., McGinn, T., Siu, A. and Federman, A. (2008), "Beliefs about generic drugs among elderly adults in hospital-based primary care practices" in Patient Education and Counseling, Vol. 73, No. 2, pp. 377-83.
34. King, D. and Kanavos, P. (2002), "Encouraging the use of generic medicines: implications for transition economies" in Croatian Medical Journal, Vol. 43, No. 4, pp. 462-9.
35. Kjoenniksen, I., Lindbaek, M. and Granas, A.G. (2006), "Patients' attitudes towards and experiences of generic drug substitution in Norway" in Pharmacy World and Science, Vol. 28, No. 5, pp. 284-9.
36. Kravitz, R., Epstein, R.M., Feldman, M.D., Franz, C.E., Azari, R., Wilkes, M.S., Hinton, L. and Franks, P. (2005), "Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial" in Journal of the American Medical Association, Vol. 293, No. 16, pp. 1995-2002.
37. Lambert, B.L., Chang, K.-Y. and Gupta, P. (2003), "Effects of frequency and similarity neighbourhoods on pharmacists' visual perception of drug names" in Social Sciences & Medicine, Vol. 57, No. 10, pp. 1939-55.
38. Lau, G.T. and Lee, S.H. (1999), "Consumers' trust in a brand and the link to brand loyalty" in Journal of Market-focused Management, Vol. 4, No. 4, pp. 341-70.
39. Leek, S. and Kun, D. (2006), "Consumer confusion in the Chinese personal computer market" in The Journal of Product & Brand Management, Vol. 15, No. 3, pp. 184-93.
40. Lindberg, M. and Lindberg, P. (2008), "Overcoming obstacles for adherence to phosphate binding medication in dialysis patients: a qualitative study" in Pharmacy World & Science, Vol. 30, No. 5, pp. 571-6.
41. Liow, K. (2009), "Understanding patients' perspective in the use of generic antiepileptic drugs: compelling lessons for physicians to improve physician/patient communication" in BMC Neurology, Vol. 9, No. 11, pp. 11-21.
42. Lofgren, H. (2004), "Generic drugs: international trends and policy developments in Australia" in Australian Health Review, Vol. 27, No. 1, pp. 39-48.
43. McDonough, R.P. and Doucette, W.R. (2003), "Using personal selling skills to promote pharmacy services" in Journal of the American Pharmacists Association, Vol. 43, No. 3, pp. 363-74.
44. McGavock, H. (1997), "Strategies to improve the cost effectiveness of general practitioner: an international perspective" in PharmacoEconomic, Vol. 12, No. 3, pp. 307-11.
45. Macdonald, E.K. and Uncles, M.D. (2007), "Consumer savvy: conceptualisation and measurement" in Journal of Marketing Management, Vol. 23, Nos 5/6, pp. 497-517.
46. Martikainen, J. and Rajaniemi, S. (2002), Drug Reimbursement Systems in EU Member States, Iceland and Norway, The Social Insurance Institution of Finland, Helsinki.
47. Mitchell, V. and Papavassiliou, V. (1999), "Marketing causes and implications of consumer confusion" in Journal of Product & Brand Management, Vol. 8, No. 4, pp. 319-39.
48. Mitchell, V.W., Walsh, G. and Yamin, M. (2005), "Towards a conceptual model of consumer confusion" in Advances in Consumer Research, Vol. 32, No. 1, pp. 143-50.
49. Motheral, B. and Heinle, S. (2004), "Predictors of satisfaction of health plan members with prescription drug benefits" in American Journal of Health-system Pharmacy, Vol. 61, No. 10, pp. 1007-14.
50. Mott, D.A. and Cline, R.R. (2002), "Exploring generic drug use behavior" in Medical Care, Vol. 40, No. 8, pp. 662-74.
51. Nørgaard, L.S., Colberg, L. and Niemann, M.R. (2001), "The role of the Danish community pharmacist: perceptions and future scenarios" in Pharmacy World and Science, Vol. 23, No. 4, pp. 153-8.
52. Papsdorf, T.B., Ablah, E., Ram, S., Sadler, T. and Liow, K. (2009), "Patient perception of generic antiepileptic drugs in the Midwestern United States" in Epilepsy & Behavior, Vol. 14, No. 1, pp. 150-3.
53. Patel, A., Gauld, R., Norris, P. and Rades, T. (2009), "This body does not want free medicines: South African consumer perceptions of drug quality" in Health Policy and Planning, Vol. 25, No. 1, pp. 61-9.
54. Pereira, J.A., Holbrook, A.M., Dolovich, L., Goldsmith, C., Thabane, L. and Douketis, J.D. (2005), "Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physicians" in Canadian Journal of Clinical Pharmacology, Vol. 12, No. 3, pp. 229-39.
55. Perri, M. and Wolfgan, A.P. (1993), "Consumers' cognitive and behavioral responses to a health care advertising campaign" in Journal of Pharmaceutical and Health Care Marketing, Vol. 6, No. 3, pp. 75-88.
56. Pottie, K., Haydt, S., Farrell, B., Dolovich, L., Sellors, C. and Hogg, W. (2008), "Narrative reports to monitor and evaluate the integration of pharmacists into family practice settings" in Annals of Family Medicine, Vol. 6, No. 2, pp. 161-5.
57. Prahalad, C. and Ramaswamy, V. (2004), The Future of Competition: Co-creating Unique Value with Customers, Harvard Business School Press, Boston, MA.
58. Ringuier, R., Rouquette, A., Dagorne, C., Garnier, F. and Fanello, S. (2008), "Connaissance et perceptions des médicaments génériques après 50 ans" in Thérapie, Vol. 63, No. 1, pp. 11-17.
59. Rizzo, J. and Zeckhauser, R. (2009), "Generic script share and the price of brand-name drugs: the role of consumer choice" in International Journal of Health Care Finance and Economics, Vol. 9, No. 3, pp. 291-316.
60. Schommer, J.C. and Wiederholt, J.B. (1997), "The association of prescription status, patient age, patient gender, and patient question asking behavior with the content of pharmacist-patient communication" in Pharmaceutical Research, Vol. 14, No. 2, pp. 145-51.
61. Seaman, R. (1997), "Case study: rejuvenating an organization with team pay" in Compensation & Benefits Review, Vol. 29, No. 5, pp. 25-30.
62. Sharrad, A.K. and Hassali, M.A. (2010), "Consumer perception on generic medicines in Basrah, Iraq: preliminary findings from a qualitative study", Research in Social and Administrative Pharmacy, available online 24 April.
63. Shrank, W., Shrank, W.H., Cox, E.R., Fischer, M.A., Mehta, J. and Choudhry, N.K. (2009), "Patients' perceptions of generic medications" in Health Affairs, Vol. 28, No. 2, pp. 546-56.
64. Steinman, M.A., Chren, M.M. and Landefeld, C.H. (2007), "What's in a name? Use of brand versus generic drug names in United States outpatient practice" in Journal of General Internal Medicine, Vol. 22, No. 5, pp. 645-8.
65. Strutton, H.D., Pelton, L.E. and Lumpkin, J.R. (1992), "The effect of consumer perceptions on generic OTC usage among the elderly" in Health Marketing Quarterly, Vol. 10, Nos 1/2, pp. 169-84.
66. Vallès, J., Barreiro, M., Cereza, G., Ferro, J.J. and Marti{dotless}Çnezet, M.J. (2003), "A prospective multicenter study of the effect of patient education on acceptability of generic prescribing in general practice" in Health Policy, Vol. 65, No. 3, pp. 269-75.
67. Van Wijk, B.L., Klungel, O.H., Heerdink, E.R. and De Boer, A. (2006), "Generic substitution of antihypertensive drugs: does it affect adherence?" in The Annals of Pharmacotherapy, Vol. 40, No. 1, pp. 15-20.
68. Vargo, S. and Lush, R.F. (2008), "Service-dominant logic: continuing the evolution" in Journal of the Academy Marketing Science, Vol. 36, No. 1, pp. 1-10.
69. Walsh, G. and Mitchell, V.W. (2005), "Demographic characteristics of consumers who find it difficult to decide" in Marketing Intelligence & Planning, Vol. 23, Nos 2/3, pp. 281-95.
70. Walsh, G., Hennig-Thura, T. and Mitchell, V.W. (2007), "Consumer confusion proneness: scale development, validation, and application" in Journal of Marketing Management, Vol. 23, Nos 7/8, pp. 697-721.
71. Walsh, K. (1994), "Marketing and public sector management" in European Journal of Marketing, Vol. 28, No. 3, pp. 63-71.
72. Webster, L. and Mertova, P. (2007), Using Narrative Inquiry as a Research Method, Routledge, Oxon.